OSNA international virtual forum - Present and future application of molecular lymph node diagnostic
Sysmex Life Science is pleased to host the first OSNA international virtual forum this November. Throughout the 7 live sessions, you will have the chance to meet, connect and discuss with 25+ experts and KOLs from different disciplines relevant to cancer diagnostics and patient management.
Meet-the-expert sessions:
Dedicated to those who want to start or expand their OSNA usage indication and who would like to hear about the newest OSNA cancer applications and how OSNA can improve lymph node management.
OSNA user meetings*:
Dedicated to the current OSNA users who are interested in learning about the ongoing and future activities, interacting and exchanging with the OSNA community and collaborating with other international experts in their fields.
*Please contact your Sysmex representative if you wish more information regarding the OSNA user meetings
REGISTER NOW! Be one of the first 50 registrants and get a coffee break package!
Workshops
Introduction to the session
Dr Vicente Peg Cámara (moderator)
Breast Pathologist at Vall d'Hebrón Hospital Barcelona,
Barcelona, Spain
TTL: beyond positive and negative
Dr Vicente Peg Cámara
Breast Pathologist at Vall d'Hebrón Hospital Barcelona,
Barcelona, Spain
How OSNA can improve efficacy and efficiency in the Breast Unit
Dr Antonio De Leo
Pathologist at Policlinico Bologna S Orsola
Bologna, Italy
OSNA BC post-NAST
Ms Pooja Padmanabhan
Breast Surgeon at Royal Surrey County Hospital Guildford,
Guildford, UK
GANEA4 trial
Dr Celine Renaudeau
Breast Surgeon at Institut de Cancerologie de l'Ouest
Nantes, France
Magseed and OSNA in the ATNEC trial
Mr Amit Goyal
Cons Oncoplastic Breast Surgeon at Royal Derby
Derby, UK
Introduction to the session
Dr Enrico Restini (moderator)
Director of General Surgery Department at Ospedale L. Bonomo
Andria, Italy
Evolving lymph node staging in colorectal carcinoma
Dr Miriam Cuatrecasas
Senior pathologist at Hospital Clinic Barcelona
Barcelona, Spain
OSNA lymph node evaluation in GI cancer
Dr Francesco Crafa
Director of General and Emergency Surgery Unit at Azienda Ospedaliera San Giuseppe Moscati
Avellino, Italy
Introduction to the session (moderator)
Lymph node mapping improves the efficiency of laparoscopic prostate surgery
Miguel Ramírez Backhaus
Clinical Chief of Urology Service at Fundación Instituto Valenciano de Oncología
Valencia, Spain
OSNA in prostate cancer: detection of lymph node metastases (POPCORN study – preliminary results)
Dr Maria Eugenia Semidey Raven
Pathologist at Hospital Vall d'Hebrón
Barcelona, Spain
Evaluating OSNA for molecular detection of lymph nodes metastases in prostate cancer
Dr Svenja Engels
Hospital for Urology, Oldenburg, Germany
Expanding the usefulness of OSNA in urological tumours: the case for sentinel lymph node biopsy in penile carcinoma
Dr Rafael J. Luque Barona
Head of Pathology Department at Hospital Universitario de Jaén
Jaén, Spain
Introduction to the session
Prof. Renato Franco (moderator)
Head of Pathology Unit at Azienda Ospedaliera Universitalia L. Vanvitelli
Napoli, Italy
Detection of lymph node metastasis in lung cancer patients using a One Step Nucleic Acid Amplification assay: a single-centre prospective study
Dr Begoña Otero Alén Biologist PhD at Complexo Hospitalario Universitario de A Coruña (CHUAC)
A Coruña, Spain
Sentinel lymph node mapping in lung cancer: a pilot study to identify the small-volume metastases using OSNA in patients with NSCLC that undergo robotic surgery
Prof. Franca Melfi
Chief of Robotic Multispecialty Center of Surgery at Azienda Ospedaliera Universitaria Pisana
Pisa, Italy
Introduction to the session
Prof. Krzysztof Nowosielski (moderator)
Professor of Gynaecology at Katowice University Hospital
Katowice, Poland
Extemporaneous assessment of sentinel nodes in early cervical cancer
Prof. Patrice Mathevet
Head of Gynaecology Department at CHUV
Lausanne, Switzerland
Rapid detection of lymph node metastases in women with endometrial cancer
Prof. Francesco Fanfani
Chief of Endometrial Cancer Surgery Unit at Policlinico Universitario Gemelli
Rome, Italy
Ultrastaging vs OSNA in gynaecological cancers
Prof. Gian Franco Zannoni
Chief GYN Breast Pathology Unit at Policlinico Universitario Gemelli
Rome, Italy
EndoOSNA: spanish multicentric study on molecular ultrastaging
Dr Maria Dolores Diestro
Onco-gynecologist at La Paz University Hospital
Madrid, Spain
Dr David Hardisson
Head of Pathology Department at La Paz University Hospital
Madrid, Spain
Additional Information